Get started
Author

Ayşegül Kargı

Observed names: A Kargi, A. Kargi, A. Kargı, Aysegul Kargi, Aysegul Odabasi Kargi, Aysegül KARGI, Aysegül Kargi, Ayşegul KARGI, Ayşegul Kargı, KARGI, Ayşegül, Kargi, Aysegul, Kargı, Ayşegül
Observed institutions: Selçuk University, Akdeniz University, Antalya Bilim Üniversitesi, Antalya Bilim University, Antalya Eğitim ve Araştırma Hastanesi, Denizli Devlet Hastanesi, Pamukkale University
ORCID: 0000-0003-4797-7313
Observed ORCID: 0000-0003-4797-7313
OpenAlex ID: A5000442883
Electromagnetic Waves and Human Health
2011 · Feyyaz Ozdemir, Aysegul Kargi · InTech eBooks · 51
PDF
Use of cryoablation beyond the prostate
2016 · Saim Yılmaz, Mustafa Özdoğan, et al. · Insights into Imaging · 34
PDF
Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer
2012 · Atil Bisgin, Aysegul Kargi, et al. · BMC Cancer · 30
PDF
Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis
2012 · Arzu Didem Yalcin, Saadet Gumuslu, et al. · Immunopharmacology and Immunotoxicology · 20
Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: Its relation to omalizumab treatment
2012 · Arzu Didem Yalcin, Atil Bisgin, et al. · Medical Science Monitor · 20
PDF
Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment.
2012 · Arzu Didem Yalcin, Reginald M Gorczynski, et al. · PubMed · 19
IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer.
2012 · Aysegul Kargi, Arzu Didem Yalcin, et al. · PubMed · 19
MDR1 single nucleotide polymorphism C3435T in Turkish patients with non-small-cell lung cancer
2012 · Gamze Gokoz Dogu, Aysegul Kargi, et al. · Gene · 14
Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer
2022 · Yusuf Ilhan, Ali Murat Tatli, et al. · International Journal of Gynecological Cancer · 13
Blood Eosinophil and Platelet Levels, Proteomics Patterns of Trail and CXCL8 Correlated with Survival in Bevacizumab Treated Metastatic Colon Cancers
2013 · Arzu D Yalcin, Aysegul Kargi, et al. · Clinical Laboratory · 12
The importance of COX-2 expression as prognostic factor in early breast cancer.
2013 · A Kargi, M Uysal, et al. · PubMed · 11
Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer.
2014 · Mukremin Uysal, Mustafa Ozdogan, et al. · PubMed · 10
Isolated and solitary splenic metastasis detected by positron emission tomography in a patient with malignant melanoma: and review of the literature
2013 · Cenk Ahmet Sen, Aysegul Kargi, et al. · Współczesna Onkologia · 10
PDF
Primary splenic angiosarcoma diagnosed after splenectomy for spontaneous rupture
2018 · Baris Ozcan, Metin Cevener, et al. · Turkish Journal of Surgery · 9
PDF
Serum levels of HMGB1 have a diagnostic role in metastatic renal cell cancer
2016 · Ayşegül Kargı, Özlem Demirpençe, et al. · Cancer Biomarkers · 9
PDF
Metronomic oral chemotherapy with old agents in patients with heavily treated metastatic breast cancer
2015 · Hasan Mutlu, FatmaYalçin Musri, et al. · Journal of Cancer Research and Therapeutics · 8
Increased Serum S-TRAIL Level in Newly Diagnosed Stage-IV Lung Adenocarcinoma but not Squamous Cell Carcinoma is Correlated with Age and Smoking
2013 · Aysegul Kargi, Atil Bisgin, et al. · Asian Pacific Journal of Cancer Prevention · 7
Erratum to "IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer" [Clin. Lab. 2012; 58:501-505].
2012 · Aysegul Kargi, Arzu Didem Yalcin, et al. · PubMed · 6
Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer.
2015 · Deniz Arslan, Deniz Tural, et al. · PubMed · 4
Real-World Outcomes in BRAF-Mutant Non-small Cell Lung Cancer: A Multicenter Analysis From the Turkish Oncology Group
2025 · Tuğba Akın Telli, Ali Murat Tatlı, et al. · Clinical Lung Cancer · 3
Ixabepilone in Metastatic Breast Cancer: Real-World Experience
2021 · Şeyda GÜNDÜZ, Dilek ERDEM, et al. · Journal of Oncological Sciences · 3
PDF
The role of VEGF and other parameters in tracking the clinical course in metronomic chemotherapy.
2013 · D Ekinci, D Ekici, et al. · PubMed · 3
Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
2006 · R Cetingöz, H O Cetinayak, et al. · PubMed · 2
Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study
2024 · Nuri Karadurmus, Muhammet Ali Kaplan, et al. · Current Medical Research and Opinion · 1
PDF
Isolated Superior Mesenteric Vein Tumor Thrombus in a Patient with Gastric Cancer
2018 · Barış Özcan, Metin Çevener, et al. · Case Reports in Surgery · 1
PDF
Works count: 56
Citation count: 324
H-index: 11
I10-index: 13
Year
Topic
Type